The Official MicroCap News Source
Watchlist News
Please Login or Register to view News Stories

SNN Q&A with DelMar Pharmaceuticals - Developing Drug Candidates Targeting Orphan Cancer Indications

SNN’s Robert Kraft spoke with Jeffrey Bacha, President and CEO of DelMar Pharmaceuticals about the company’s drug candidates, what orphan cancer indications DelMar is targeting, and 2015 objectives.

Share With

Thursday, February 26, 2015

   

© 2017 Stock News Now